California’s Department of Cannabis Control has opened formal rulemaking DCC-2026-04-R to make permanent a process that lets retailers holding a combined adult-use and medicinal license split it into two. Written comments close December 14, 2026, and a public hearing is set for December 15 at 10:00 a.m. The stated purpose is to let licensees pursue DEA registration under the April 2026 Schedule III order, and the department itself says that registration “may take years for approval.”
Today a California retail license can carry both an Adult-Use (A) and a Medicinal (M) designation. The department says that without a rule, a dual-designated licensee that wants separate licenses must withdraw its license and file two new applications. The proposal, built on authority in Business and Professions Code sections 26012 and 26013, lets an eligible licensee be issued separate A and M licenses through an expedited, voluntary process. The new M license may go to a different legal entity if the conditions are met. The department’s notice estimates about 1,600 licensees could use it, roughly 97 percent of them small businesses, mostly retailers and microbusinesses.
The proposed text, in sections 15000.2 and 15023.1, sets the mechanics. Only retail-authorized licensees holding a combined designation qualify. A licensee emails a request to licensechange@cannabis.ca.gov with the M license name, the designated responsible party, formation documents, the federal employer identification number and the California seller’s permit number. The department says it will review within five business days. The annual M license fee must be paid before inventory moves, and no new fee is due for the remainder of the current license period. Existing inventory stays under the A license’s track-and-trace account, so the M license starts with no stock and must source its own.
This is the second step, not the first. The department’s statement of reasons says it adopted emergency regulations on June 4, 2026, that already allow a separate medicinal license held by a separate entity, and that 95 licensed businesses have used them. DCC-2026-04-R proposes to adopt those rules formally, which we first covered in our report on the expedited A/M split. The permanent text can change after comment, and one subsection, section 15000.1(e), appears in the posted draft with unresolved tracked-change markup, so confirm final wording against the official version before relying on it.
Sequencing matters here. The permanent rule cannot be final before the DEA’s November 29, 2026 supply-chain deadline, since comments run to December 14. Whatever split path exists today is the operative one, which is the emergency process. The permanent rule matters for the long run: how the different-entity option survives, and how the liability terms are finally written.
| License structure | Federal position after the April 2026 order | Practical constraint |
|---|---|---|
| Combined A/M retail license | Mixed activity under one license; the department says a split is needed to pursue DEA registration cleanly | Without the rule, withdraw and reapply for two licenses |
| Split M license | Can pursue DEA registration as a medical business | Same owners and responsible party; joint and several liability; starts with no inventory |
| A license only | Outside the order; the department says adult-use cannabis remains illegal under federal law | Keeps existing inventory and sales |
California is a structural outlier. The seven states in DEA’s first registration batch (Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia) license medical operators under a medical framework, so there is no combined license to split. California’s dual-designation retail model is what makes its operators do the restructuring first. Oklahoma has medical-only licensing too, yet was not in the first batch, so the constraint there is timing and supply-chain diligence rather than license design.
For the federal side of the line, see medical versus adult-use after rescheduling and the pending Schedule III proceeding. California’s other cannabis-adjacent rules, from AB 8 hemp moving into the cannabis market to the state’s vape rules, run on separate tracks. Registered operators should also review payments and banking options.
Under the department’s emergency regulations adopted June 4, 2026, yes for eligible retail licensees. DCC-2026-04-R proposes to make that process permanent.
December 14, 2026. The public hearing is December 15 at 10:00 a.m., by WebEx or phone, with limited seating in Rancho Cordova.
The department says the split lets licensees pursue DEA registration after the April 2026 Schedule III order, which it says may help with the Section 280E deduction disallowance.
Not under the proposal. The A and M entities must share the same owners and responsible party and are jointly and severally liable for obligations and violations under either license.
No. Existing inventory stays under the A license’s track-and-trace account, and the M license must obtain its own.
This is regulatory journalism, not legal advice — talk to your counsel.
